Search

everythinglearnresearchcommunity

for

Search:↓

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

Minoxidil and finasteride effectively treat hair loss.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

New understanding and treatments for hair loss are improving, but more research is needed.

Nutritional supplements may help improve hair growth in female pattern hair loss.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Common baldness treatments include cosmetic methods, medication like minoxidil, and surgery, but no cure exists.

Thyroid problems are linked to various skin issues, and checking thyroid health is important for people with certain skin conditions.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Dermoscopy shows that diffuse alopecia areata progresses through specific hair growth stages.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Transplanted hair follicles can resist hair loss from an autoimmune condition better than natural hair.

The author clarifies that alopecia areata incognito and diffuse alopecia areata are different types of hair loss with unique symptoms and challenges in diagnosis.

A woman's hair loss was misdiagnosed as alopecia areata but was actually lichen planopilaris, needing immediate and ongoing treatment.

The author clarified that Alopecia Areata Incognita (AAI) and diffuse Alopecia Areata (AA) are different conditions and the case discussed was actually AA, not AAI.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.